Why is Neuronetics, Inc. ?
- OPERATING CASH FLOW(Y) Lowest at USD -34.51 MM
- NET PROFIT(HY) At USD -22.8 MM has Grown at -28.75%
- ROCE(HY) Lowest at -207.57%
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 7.52%, its profits have fallen by -58.3%
How much should you hold?
- Overall Portfolio exposure to Neuronetics, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Neuronetics, Inc. for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Higher at USD -22.8 MM
Highest at 9.29 times
Highest at USD 38.11 MM
Highest at USD -7.16 MM
Highest at -18.78 %
Highest at USD -0.15
Lowest at USD -34.51 MM
At USD -22.8 MM has Grown at -28.75%
Lowest at -207.57%
Highest at 232.11 %
Grown by 37.94% (YoY
Lowest at USD 39.07 MM
Here's what is working for Neuronetics, Inc.
Net Sales (USD MM)
Net Sales (USD MM)
Net Profit (USD MM)
Inventory Turnover Ratio
Operating Profit (USD MM)
Operating Profit to Sales
EPS (USD)
Here's what is not working for Neuronetics, Inc.
Net Profit (USD MM)
Debt-Equity Ratio
Operating Cash Flows (USD MM)
Cash and Cash Equivalents
Raw Material Cost as a percentage of Sales






